Cerebral Ischemia Enhances Vascular Angiotensin AT1 Receptor-Mediated Contraction in Rats

Stroke

Volumn 35, Issue 4, 2004, Pages 970-974

  Stenman, Emelie ^a   Edvinsson, Lars ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

Angiotensin converting enzyme inhibitors; Angiotensins; Cerebral ischemia; Receptors, angiotensin

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; CANDESARTAN; DIPEPTIDYL CARBOXYPEPTIDASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LOSARTAN; MESSENGER RNA;

ANIMAL MODEL; ARTICLE; BLOOD VESSEL; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NONHUMAN; PRIORITY JOURNAL; RAT; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION;

ANGIOTENSIN II; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; BENZIMIDAZOLES; BRAIN ISCHEMIA; CULTURE TECHNIQUES; INFARCTION, MIDDLE CEREBRAL ARTERY; LOSARTAN; MALE; MIDDLE CEREBRAL ARTERY; PEPTIDYL-DIPEPTIDASE A; RATS; RATS, WISTAR; RECEPTOR, ANGIOTENSIN, TYPE 1; RNA, MESSENGER; TETRAZOLES; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS;

EID: 1842523271     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000121642.53822.58     Document Type: Article

References (21)

1. Perich R, Jackson B, Paxton D, Johnston CI. Characterization of angiotensin convening enzyme in isolated cerebral microvessels from spontaneously hypertensive and normotensive rats. J Hypertens. 1992;10:149-153.
2. Allen GS, Henderson LM, Chou SN, French LA. Cerebral arterial spasm, 1: in vitro contractile activity of vasoactive agents on canine basilar and middle cerebral arteries. J Neurosurg. 1974;40:433-441.
3. Edvinsson L, Hardebo JE, Owman C. Effects of angiotensin II on cerebral blood vessels. Acta Physiol Scand. 1979;105:381-383.
4. Toda N, Miyazaki M. Heterogeneous responses to vasodilators of dog proximal and distal middle cerebral arteries. J Cardiovasc Pharmacol. 1984;6:1230-1237.
5. 1 receptor mediated contraction of the perfused rat cerebral artery. Neuroreport. 1994;5:2278-2280.
6. B receptors in rat. Stroke. 2002;33:2311-2316.
7. Heinemeyer T, Wingender E, Reuter I, Hermjakob H, Kel AE, Kel OV, Ignatieva EV, Ananko EA, Podkolodnaya OA, Kolpakov FA, Podkolodny NL, Kolchanov NA. Databases on transcriptional regulation: TRANSFAC, TRRD and COMPEL. Nucleic Acids Res. 1998;26:362-367.
8. Memezawa H, Minamisawa H, Smith ML, Siesjo, BK. Ischemic penumbra in a model of reversible middle cerebral artery occlusion in the rat. Exp Brain Res. 1992;89:67-78.
9. Bederson JB, Pitts LH, Germano SM, Nishimura MC, Davis RL, Bartkowski HM. Evaluation of 2,3,5-triphenyltetrazolium chloride as a stain for detection and quantification of experimental cerebral infarction in rats. Stroke. 1986;17:1304-1308.
10. Mulvany MJ, Halpern W. Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats. Circ Res. 1977;41:19-26.
11. Hogestatt ED, Andersson KE, Edvinsson L. Mechanical properties of rat cerebral arteries as studied by a sensitive device for recording of mechanical activity in isolated small blood vessels. Acta Physiol Scand. 1983;117:49-61.
12. Memezawa H, Smith ML, Siesjo, BK. Penumbral tissues salvaged by reperfusion following middle cerebral artery occlusion in rats. Stroke. 1992;23:552-559.
13. Kiyota Y, Pahlmark K, Memezawa H, Smith ML, Siesjo BK. Free radicals and brain damage due to transient middle cerebral artery occlusion: the effect of dimethylthiourea. Exp Brain Res. 1993;95: 388-396.
14. 1 blockade normalizes cerebrovascular autoregulation and reduces cerebral ischemia in spontaneously hypertensive rats. Stroke. 2000;31:2478-2486.
15. 1 receptor inhibition. J Cereb Blood Flow Metab. 2003;23:371-380.
16. Dahlof B, Devereux RB, Kjeldsen SE, Julius S, Beevers G, Faire U, Fyhrquist F, Ibsen H, Kristiansson K, Lederballe-Pedersen O, Lindholm LH, Nieminen MS, Omvik P, Oparil S, Wedel H. Cardiovascular morbidity and mortality in the losartan intervention for endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet. 2002;359:995-1003.
17. Lithell H, Hansson L, Skoog I, Elmfeldt D, Hofman A, Olofsson B, Trenkwalder P, Zanchetti A. The study on cognition and prognosis in the elderly (SCOPE): principal results of a randomized double-blind intervention trial. J Hypertens. 2003;21:875-886.
18. Schrader J, Luders S, Kulschewski A, Berger J, Zidek W, Treib J, Einhaupl K, Diener HC, Dominiak P. The ACCESS study: evaluation of acute candesartan cilexetil therapy in stroke survivors. Stroke, 2003;34: 1699-1703.
19. Werner C, Hoffman WE, Kochs E, Rabito SF, Miletich DJ, Captopril improves neurologic outcome from incomplete cerebral ischemia in rats. Stroke. 1991;22:910-914.
20. Fujii K, Weno BL, Baumbach GL, Heistad DD. Effect of antihypertensive treatment on focal cerebral infarction. Hypertension. 1992;19: 713-716.
21. Bosch J, Yusuf S, Pogue J, Sleight P, Lonn E, Rangoonwala B, Davies R, Ostergren J, Probstfield J. Use of ramipril in preventing stroke: double blind randomised trial. BMJ. 2002;324:699-702.